Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
378.44 USD | +0.22% |
|
-2.85% | +26.08% |
30/06 | HCA Healthcare, Inc.(NYSE:HCA) added to Russell 1000 Value-Defensive Index | CI |
30/06 | HCA Healthcare, Inc.(NYSE:HCA) added to Russell 1000 Growth-Defensive Index | CI |
Company Valuation: HCA Healthcare, Inc.
Data adjusted to current consolidation scope
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 55,649 | 79,908 | 67,841 | 72,450 | 76,027 | 91,043 | - | - |
Change | - | 43.59% | -15.1% | 6.79% | 4.94% | 19.75% | - | - |
Enterprise Value (EV) 1 | 84,860 | 1,13,036 | 1,05,017 | 1,11,108 | 1,17,125 | 1,35,674 | 1,36,493 | 1,36,730 |
Change | - | 33.2% | -7.09% | 5.8% | 5.42% | 15.84% | 0.6% | 0.17% |
P/E ratio | 15x | 12.1x | 12.5x | 14.3x | 13.6x | 14.9x | 13.4x | 11.9x |
PBR | 98.8x | -90.5x | -25.6x | -40.5x | -30x | -22.6x | -30.1x | -59.6x |
PEG | - | 0.1x | -1.32x | -15.21x | 0.9x | 1x | 1.2x | 0.9x |
Capitalization / Revenue | 1.08x | 1.36x | 1.13x | 1.12x | 1.08x | 1.22x | 1.16x | 1.1x |
EV / Revenue | 1.65x | 1.92x | 1.74x | 1.71x | 1.66x | 1.82x | 1.74x | 1.65x |
EV / EBITDA | 8.45x | 8.94x | 8.7x | 8.73x | 8.44x | 9.15x | 8.8x | 8.34x |
EV / EBIT | 11.6x | 11.5x | 11.5x | 11.5x | 11.1x | 12x | 11.5x | 10.9x |
EV / FCF | 13.3x | 21x | 25.4x | 23.7x | 20.8x | 21.7x | 22.1x | 19x |
FCF Yield | 7.54% | 4.76% | 3.93% | 4.22% | 4.81% | 4.62% | 4.52% | 5.26% |
Dividend per Share 2 | 0.43 | 1.92 | 2.24 | 2.4 | 2.64 | 2.839 | 2.948 | 3.03 |
Rate of return | 0.26% | 0.75% | 0.93% | 0.89% | 0.88% | 0.75% | 0.78% | 0.8% |
EPS 2 | 10.93 | 21.16 | 19.15 | 18.97 | 22 | 25.32 | 28.15 | 31.92 |
Distribution rate | 3.93% | 9.07% | 11.7% | 12.7% | 12% | 11.2% | 10.5% | 9.49% |
Net sales 1 | 51,533 | 58,752 | 60,233 | 64,968 | 70,603 | 74,732 | 78,512 | 82,642 |
EBITDA 1 | 10,037 | 12,644 | 12,067 | 12,726 | 13,882 | 14,833 | 15,518 | 16,386 |
EBIT 1 | 7,316 | 9,791 | 9,098 | 9,649 | 10,570 | 11,291 | 11,822 | 12,489 |
Net income 1 | 3,754 | 6,956 | 5,643 | 5,242 | 5,760 | 6,175 | 6,480 | 6,943 |
Net Debt 1 | 29,211 | 33,128 | 37,176 | 38,658 | 41,098 | 44,631 | 45,450 | 45,688 |
Reference price 2 | 164.46 | 256.92 | 239.96 | 270.68 | 300.15 | 378.44 | 378.44 | 378.44 |
Nbr of stocks (in thousands) | 3,38,375 | 3,11,023 | 2,82,717 | 2,67,661 | 2,53,297 | 2,40,574 | - | - |
Announcement Date | 02/02/21 | 27/01/22 | 27/01/23 | 30/01/24 | 24/01/25 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
---|---|---|---|---|---|---|
14.91x | 1.81x | 9.13x | 0.75% | 9.08TCr | ||
15.37x | 0.35x | 8.49x | 4.13% | 8.47TCr | ||
15.17x | 1.54x | 9.27x | 2.5% | 2.77TCr | ||
37.94x | 7.34x | 31.21x | 1.83% | 2.52TCr | ||
21.29x | 1.88x | 10.95x | 1.12% | 2.15TCr | ||
20.22x | 2.29x | 11.35x | 1.75% | 1.93TCr | ||
14.88x | 1.19x | 6.35x | 3.15% | 1.62TCr | ||
13.84x | 1.24x | 6.26x | -.--% | 1.6TCr | ||
67.25x | 11.87x | 44.43x | 0.15% | 1.47TCr | ||
18.47x | 1.36x | 7.71x | 1.89% | 1.41TCr | ||
Average | 23.94x | 3.09x | 14.51x | 1.73% | 3.3TCr | |
Weighted average by Cap. | 19.96x | 2.24x | 12.15x | 2.03% |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- HCA Stock
- Valuation HCA Healthcare, Inc.
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition